Human Leukocyte Antigen-G: A Promising Prognostic Marker of Disease Progression to Improve the Control of Human African Trypanosomiasis

Carregando...
Imagem de Miniatura

Data

2016-11-01

Autores

Gineau, Laure
Courtin, David
Camara, Mamadou
Ilboudo, Hamidou
Jamonneau, Vincent
Dias, Fabricio C.
Tokplonou, Leonidas
Milet, Jacqueline
Mendonça, Priscila B.
Castelli, Erick C. [UNESP]

Título da Revista

ISSN da Revista

Título de Volume

Editor

Resumo

Background. Human African trypanosomiasis (HAT) caused by Trypanosoma brucei gambiense can be diagnosed in the early hemolymphatic stage (stage 1 [S1]) or meningoencephalitic stage (stage 2 [S2]). Importantly, individuals harbouring high and specific antibody responses to Tbg antigens but negative parasitology are also diagnosed in the field (seropositive [SERO]). Whereas some develop the disease in the months following their initial diagnosis (SERO/HAT), others remain parasitologically negative for long periods (SERO) and are apparently able to control infection. Human leucocyte antigen (HLA)-G, an immunosuppressive molecule, could play a critical role in this variability of progression between infection and disease. Methods. Soluble HLA-G (sHLA-G) was measured in plasma for patients in the SERO (n = 65), SERO/HAT (n = 14), or HAT (n = 268) group and in cerebrospinal fluid for patients in S1 (n = 55), early S2 (n = 93), or late S2 (n = 110). Associations between these different statuses and the soluble level or genetic polymorphisms of HLA-G were explored. Results. Plasma sHLA-G levels were significantly higher in HAT (P = 6 × 10-7) and SERO/HAT (P =. 007) than SERO patients. No difference was observed between the SERO/HAT and HAT groups. Within the HAT group, specific haplotypes (HG010102 and HG0103) displayed increased frequencies in S1 (P =. 013) and late S2 (P =. 036), respectively. Conclusions. These results strongly suggest the involvement of HLA-G in HAT disease progression. Importantly, high plasma sHLA-G levels in SERO patients could be predictive of subsequent disease development and could represent a serological marker to help guide therapeutic decision making. Further studies are necessary to assess the predictive nature of HLA-G and to estimate both sensitivity and specificity.

Descrição

Palavras-chave

genetic association, HLA-G, human African trypanosomiasis, susceptibility, Trypanosoma brucei gambiense

Como citar

Clinical Infectious Diseases, v. 63, n. 9, p. 1189-1197, 2016.